Report title: Phoqus Pharmaceuticals PLC (FKA: Phoqus Group, Ltd.) - Portfolio Company Report
from Thomson Financial Venture Economics
published May 16, 2009

Price $24.00 available for immediate download
Report Overview
 
About Thomson Financial Venture Econ...

Develops medical technology for new chemical entities (NCEs). The Companys product Chronocort, is a Phase II clinical trial product used for the treatment of congenital adrenal hyperplasia and Addison's disease. Its drug delivery platform, Qtrol, which is derived from electrostatic deposition, enables solid oral dosage forms, such as tablets to be coated in a controlled and precise manner that could then be used to modify the way that a drug is released into the body. ; Develops medical technology for new chemical entities (NCEs).

Report Type: This research report shows venture capital financing information for this specific company.
Executives Listed: 21
Number of Investing Funds: 8
Free Sample: Click Here to Download
Format:
PDF Adobe Acrobat


Price: $24.00



  Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.